Activist hedge fund Parvus builds stake in Novo Nordisk, FT reports
Published on 2025-06-09 at 14:14

Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
498.10 DKK | -3.51% |
|
-4.17% | -20.20% |
12:44pm | European shares snap five-day losing streak | RE |
11:03am | European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading | MT |
Published on 2025-06-09 at 14:14
Mr. Lars Fruergaard Jørgensen is a Vice President at European Federation of Pharmaceutical Industries & Assns, a Vice Chairman-Supervisory Board at Carlsberg A/S, a Member-Supervisory Board at Carlsberg Breweries A/S, a President & Chief Executive Officer at Novo Nordisk Ltd., a President & Chief Executive Officer at Novo Nordisk A/S and a Chairman at Harno Invest A/S. He is on the Board of Directors at Carlsberg A/S and Carlsberg Breweries A/S. Mr. Jørgensen was previously employed as a Member-Supervisory Board by Innate Pharma SA, a Vice President-Finance & Information Technology by Novo Nordisk Pharmaceutical SAS, and a Chairman by NNE Pharmaplan A/S. He also served on the board at ZymoGenetics, Inc. and NNIT A/S. He received his graduate degree from the University of Aarhus.
View full profileSelect your edition
All financial news and data tailored to specific country editions